In 2020, CDER accredited two new therapies for neuromyelitis optica spectrum disorder. Ga 68 PSMA-11 (accredited without trade name), a positron emission tomography (PET) imaging agent for detection and localization of prostate most cancers, an important advance that offers a far more precise imaging option for people with prostatic most cancers, o